Price Chart

Profile

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
URL https://www.immatics.com
Investor Relations URL https://investors.immatics.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 21, 2024 (est.)
Last Earnings Release Nov. 14, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
URL https://www.immatics.com
Investor Relations URL https://investors.immatics.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 21, 2024 (est.)
Last Earnings Release Nov. 14, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A